Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Han Ng

Showing results (141-150 of 207) with videos related to

Pageof 21
Sort By:
JAMA Network Open|August 16, 2023
Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019Benjamin Koh, Darren Jun Hao Tan, Cheng Han Ng, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Meta-Analysis: Utilisation of Hepatocellular Carcinoma SurveillanceNicole Shu Ying Tang, Shyna Gunalan, Christen En Ya Ong, et al.
Annals of Hepatology|October 1, 2022
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysisMark Muthiah, Cheng Han Ng, Kai En Chan, et al.
Hepatology International|March 23, 2022
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysisJie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2025
High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: A Meta-analysisGlenn Jun Kit Ho, Faith Xin Ning Tan, N Apoorva Sasikumar, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Placebo effect on progression and regression in NASH: Evidence from a meta-analysisCheng Han Ng, Jieling Xiao, Wen Hui Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2022
UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 StudiesDarren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2022
The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese IndividualsKai En Chan, Cheng Han Ng, Clarissa Elysia Fu, et al.
Transplantation Direct|June 24, 2024
Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASHJia Hong Koh, Douglas Chee, Cheng Han Ng, et al.
Transplantation|July 13, 2023
Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver CirrhosisWen Hui Lim, Cheng Han Ng, Darren Jun Hao Tan, et al.
Pageof 21

Showing results (141-150 of 207) with videos related to

Sort By:
Pageof 21
JAMA Network Open|August 16, 2023
Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019Benjamin Koh, Darren Jun Hao Tan, Cheng Han Ng, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2025
Meta-Analysis: Utilisation of Hepatocellular Carcinoma SurveillanceNicole Shu Ying Tang, Shyna Gunalan, Christen En Ya Ong, et al.
Annals of Hepatology|October 1, 2022
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysisMark Muthiah, Cheng Han Ng, Kai En Chan, et al.
Hepatology International|March 23, 2022
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysisJie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 9, 2025
High Global Prevalence of Steatotic Liver Disease and Associated Subtypes: A Meta-analysisGlenn Jun Kit Ho, Faith Xin Ning Tan, N Apoorva Sasikumar, et al.
Hepatology (Baltimore, Md.)|January 6, 2022
Placebo effect on progression and regression in NASH: Evidence from a meta-analysisCheng Han Ng, Jieling Xiao, Wen Hui Lim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 19, 2022
UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 StudiesDarren Jun Hao Tan, Wen Hui Lim, Jie Ning Yong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2022
The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese IndividualsKai En Chan, Cheng Han Ng, Clarissa Elysia Fu, et al.
Transplantation Direct|June 24, 2024
Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASHJia Hong Koh, Douglas Chee, Cheng Han Ng, et al.
Transplantation|July 13, 2023
Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver CirrhosisWen Hui Lim, Cheng Han Ng, Darren Jun Hao Tan, et al.
Pageof 21